Company Directory / research

IgGenix logo

PrivateFor profitresearchSouth San Francisco, United States

IgGenix

IgGenix is a biotechnology company.

Founded
2019
7 years ago
Staff
1-10
band, as listed
Followers
-
on LinkedIn
Funding
$75M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

1-10 people: larger than 0% of companies with a size listed

Age

201919002026

7 years old.

Reach

Website ranked #4,336,028 in the world for traffic, about 2k visits a month.

What it does

BiotechnologyHealth CareMedical

Funding, as listed

$75M currency not stated

  • Rounds4
  • LatestSeries b, Feb 2023
  • Investors9, 3 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersBruce Hironaka, Derek Croote, Jessica Grossman, Kari Nadeau, Richard Boismenu, Stephen Quake

Every detail we hold

Everything the source datasets list about IgGenix, field by field. Contact details are held but never shown.

The company

Name
IgGenix
Type
For profit
Status
Private
Founded
2019
Founders
Bruce Hironaka, Derek Croote, Jessica Grossman, Kari Nadeau, Richard Boismenu, Stephen Quake
Industry
research
Categories
Biotechnology, Health Care, Medical

Where

City
South San Francisco
Country
United States
Markets
San Francisco Bay Area, West Coast, Western US

Size and reach

Staff band
1-10
Web traffic rank
#4,336,028
Monthly web visits
2,300

Funding, as listed

Total
75,000,000 (currency not stated)
Rounds
4
Latest round
Series b
Latest round date
Feb 2023
Investors
9
Lead investors
3
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

IgGenix may be growing as it has published new data supporting the further development of allergen-specific treatments, which indicates progress in its research and development efforts. The company is also working on creating an injection for patients to prevent allergic reactions, which suggests an expansion of its product pipeline. Furthermore, being based in San Francisco, a hub for biotechnology innovation, IgGenix is positioned in a strategic location that could facilitate its growth in the health care and medical industries.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

research in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.